These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38194773)

  • 1. Peptide-drug conjugates: A new paradigm for targeted cancer therapy.
    Wang M; Liu J; Xia M; Yin L; Zhang L; Liu X; Cheng Y
    Eur J Med Chem; 2024 Feb; 265():116119. PubMed ID: 38194773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?
    Fu C; Yu L; Miao Y; Liu X; Yu Z; Wei M
    Acta Pharm Sin B; 2023 Feb; 13(2):498-516. PubMed ID: 36873165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress and Future Directions with Peptide-Drug Conjugates for Targeted Cancer Therapy.
    Lindberg J; Nilvebrant J; Nygren PÅ; Lehmann F
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Targeted Cancer Therapy: Are PDCs the Next Generation of ADCs?
    Zhang B; Wang M; Sun L; Liu J; Yin L; Xia M; Zhang L; Liu X; Cheng Y
    J Med Chem; 2024 Jul; 67(14):11469-11487. PubMed ID: 38980167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells.
    Kalimuthu K; Lubin BC; Bazylevich A; Gellerman G; Shpilberg O; Luboshits G; Firer MA
    J Nanobiotechnology; 2018 Mar; 16(1):34. PubMed ID: 29602308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-Assisted Delivery of a Peptide-Drug Conjugate for Targeted Cancer Therapy.
    Kim H; Hwang D; Choi M; Lee S; Kang S; Lee Y; Kim S; Chung J; Jon S
    Mol Pharm; 2019 Jan; 16(1):165-172. PubMed ID: 30521347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivalent protein-drug conjugates - An emerging strategy for the upgraded precision and efficiency of drug delivery to cancer cells.
    Porębska N; Ciura K; Chorążewska A; Zakrzewska M; Otlewski J; Opaliński Ł
    Biotechnol Adv; 2023 Oct; 67():108213. PubMed ID: 37453463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide Drug Conjugates and Their Role in Cancer Therapy.
    Heh E; Allen J; Ramirez F; Lovasz D; Fernandez L; Hogg T; Riva H; Holland N; Chacon J
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide-Drug Conjugate: A Novel Drug Design Approach.
    Ma L; Wang C; He Z; Cheng B; Zheng L; Huang K
    Curr Med Chem; 2017; 24(31):3373-3396. PubMed ID: 28393694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptides as a platform for targeted therapeutics for cancer: peptide-drug conjugates (PDCs).
    Cooper BM; Iegre J; O' Donovan DH; Ölwegård Halvarsson M; Spring DR
    Chem Soc Rev; 2021 Feb; 50(3):1480-1494. PubMed ID: 33346298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug conjugate-based anticancer therapy - Current status and perspectives.
    Yang Y; Wang S; Ma P; Jiang Y; Cheng K; Yu Y; Jiang N; Miao H; Tang Q; Liu F; Zha Y; Li N
    Cancer Lett; 2023 Jan; 552():215969. PubMed ID: 36279982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide-Drug Conjugates with Different Linkers for Cancer Therapy.
    Alas M; Saghaeidehkordi A; Kaur K
    J Med Chem; 2021 Jan; 64(1):216-232. PubMed ID: 33382619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxime-Linked Peptide-Daunomycin Conjugates as Good Tools for Selection of Suitable Homing Devices in Targeted Tumor Therapy: An Overview.
    Mező G; Gomena J; Ranđelović I; Dókus EL; Kiss K; Pethő L; Schuster S; Vári B; Vári-Mező D; Lajkó E; Polgár L; Kőhidai L; Tóvári J; Szabó I
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule- and peptide-drug conjugates addressing integrins: A story of targeted cancer treatment.
    Paulus J; Sewald N
    J Pept Sci; 2024 Jul; 30(7):e3561. PubMed ID: 38382900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide cargo administration: current state and applications.
    Rohira H; Arora A; Kaur P; Chugh A
    Appl Microbiol Biotechnol; 2023 May; 107(10):3153-3181. PubMed ID: 37052636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Learn from antibody-drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy.
    Wu M; Huang W; Yang N; Liu Y
    Exp Hematol Oncol; 2022 Nov; 11(1):93. PubMed ID: 36348391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review on Exploring the Opportunities of Polymer Drug Conjugated Systems for Targeted Cancer Treatment.
    Gupta C; Naik I; Menon M; Ambre P; Coutinho E
    Curr Drug Deliv; 2022; 20(1):8-30. PubMed ID: 35400344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Peptide Paratope Mimics Derived from the Anti-ROR1 Antibody and Long-Acting Peptide-Drug Conjugates for Targeted Cancer Therapy.
    Zhang Y; Fan Y; Liu S; Guan Y; Wan J; Ren Q; Wang J; Zhong L; Hu Z; Shi W; Qian H
    J Med Chem; 2024 Jul; 67(13):10967-10985. PubMed ID: 38943600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in targeted therapy for pancreatic cancer.
    Xing L; Lv L; Ren J; Yu H; Zhao X; Kong X; Xiang H; Tao X; Dong D
    Biomed Pharmacother; 2023 Dec; 168():115717. PubMed ID: 37862965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted drug delivery for cancer therapy: the other side of antibodies.
    Firer MA; Gellerman G
    J Hematol Oncol; 2012 Nov; 5():70. PubMed ID: 23140144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.